Trial Details

UNKNOWN
Basic Information
Clinical ID c1653
Identifier NCT03938701
Trial Title Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD|Rheumatoid Arthritis
Interventions DRUG: Adalimumab-800CW|DEVICE: Fluorescence Imaging
Participant Information
Sponsor University Medical Center Groningen
City Groningen
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-06-23
Primary Completion Date 2025-06-24
Completion Date 2025-12-24